** Shares of Glenmark Pharmaceuticals GLEN.NS up ~4% to 1350.5 rupees
** Co settles remaining antitrust and consumer protection lawsuits with three plaintiffs in connection with generic cholesterol drug Zetia
** Plaintiffs include Humana HUM.N, Centene Corp CNC.N
and Kaiser Foundation Health Plan [RIC:RIC:KISERF.UL]
** Under terms of $7 mln settlement, Glenmark denies allegations by plaintiffs, concedes no liability
** Including session's gains, GLEN shares up 48.3% in the last 12 months
(Reporting by Ananta Agarwal in Bengaluru)
((Ananta.Agarwal@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。